NYMOX PHARMACEUTICAL CORPORATION Proceeds From Borrowings Classified As Financing Activities
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Proceeds From Borrowings Classified As Financing Activities of $2.67 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2025-06-03
| Period end | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|
| 2024-12-31 | $2.67M 20-F · filed 2025-06-03 |
| 2023-12-31 | $1.75M 20-F · filed 2025-06-03 |